Get more info

Get more information
on LUCENTIS:
1-866-LUCENTIS
(1-866-582-3684)

Monday-Friday
8AM-9PM (EST)

You'll receive helpful tips & tools, a free information kit, and much more.

Sign Up Now
 


Click here for Questions to Ask Your Doctor.

How one woman learned to cope with AMD.

Be Informed
   

LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).

LUCENTIS is a breakthrough treatment for wet AMD that can do more than just help you maintain your vision. With LUCENTIS, people with wet AMD may see their vision improve or keep the vision they have.

LUCENTIS is an FDA-approved treatment specifically developed for the treatment of wet AMD.

Of patients in key clinical studies taking LUCENTIS monthly...

  • Up to 40% of patients had a significant improvement of at least 3 more lines (15 letters) on the eye chart


  • 70% of patients could see at least 1 more letter on the eye chart


  • 95% of patients had their eyesight stay the same (lost fewer than 15 letters or 3 lines)


  • Up to 40% of patients achieved vision of 20/40 or better


And did you know that LUCENTIS...

Was specifically developed for use in the eye, and is FDA approved for the treatment of wet AMD?







Who is LUCENTIS for?


LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).


Important LUCENTIS Safety Information


Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.


Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.


Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.


Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.


The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.


LUCENTIS is for prescription use only.

Individual results with LUCENTIS may vary.


Please see LUCENTIS full Prescribing Information.